Pharmacogenomics of g protein-coupled receptor: Signaling insights from health and disease

Methods in Molecular Biology

Volumn 448, Issue , 2008, Pages 77-107

  Thompson, Miles D ^a   Cole, David E C ^a   Jose, Pedro A ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Accessory proteins; G protein coupled receptor; G protein coupled receptor kinases; Hypertension; Pharmacogenomics; Signaling

Indexed keywords

EID: 84934443716     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-205-2_6     Document Type: Article

References (192)

1. Bargmann, C. I. (1998) Neurobiology of the Caenorhabditis elegans genome. Science. 282, 2028-33.
2. Pierce, K. L., Premont, R. T., and Lefkowitz, R. J. (2002) Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650.
3. Rashid, A. J., O'Dowd, B. F., and George, S. R. (2004) Minireview: diversity and complexity of signaling through peptidergic G protein-coupled receptors. Endocrinology. 145, 2645-2652.
4. Libert, F., Vassart, G., and Parmentier, M. (1991) Current developments in G-protein-coupled receptors. Curr. Opin. Cell Biol. 3, 218-223.
5. Odowd, B. F., Nguyen, T., Lynch, K. R., et al. (1996) A novel gene codes for a putative G protein-coupled receptor with an abundant expression in brain. FEBS Lett. 394, 325-329.
6. Civelli, O., Nothacker, H. P., Bourson, A., Ardati, A., Monsma, F., and Reinscheid, R. (1997) Orphan receptors and their natural ligands. J. Recept. Signal Transduct. Res. 17, 545-550.
7. Stadel, J. M., Wilson, S., and Bergsma, D. J. (1997) Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. Trends Pharmacol. Sci. 18, 430-437.
8. Wilson, S., Bergsma, D. J., Chambers, J. K., et al. (1998) Orphan G-protein-coupled receptors: the next generation of drug targets? Br. J. Pharmacol. 125, 1387-1392.
9. Sakurai, T., Amemiya, A., Ishii, M., et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior [see comments]. Cell. 92, 573-585.
10. Howard, A. D., McAllister, G., Feighner, S. D., et al. (2001) Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol. Sci. 22, 132-140.
11. Thompson, M. D., Gravesandeg, K. S. V., Galczenski, H., et al. (2003) A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da Cunha. Pharmacogenetics. 13, 641-649.
12. Liu, X., Davis, D., and Segaloff, D. L. (1993) Disruption of potential sites for N-linked glycosylation does not impair hormone binding to the lutropin/choriogonadotropin receptor if Asn173 is left intact. J. Biol. Chem. 268, 1513-1516.
13. 1, dopamine receptors in transfected mammalian cells. Mol. Pharmacol. 56, 1071-1078.
14. Karnik, S. S., Ridge, K. D., Bhattacharya, S., and Khorana, H. G. (1993) Palmitoylation of bovine opsin and its cysteine mutants in COS cells. Proc. Natl. Acad. Sci. U. S. A. 90, 40-44.
15. 1 receptor does not affect receptor-G protein interaction. Eur. J. Pharmacol. 324, 109-116.
16. Ovchinnikov, Y., Abdulaev, N., and Bogachuk, A. (1988) Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitoylated. FEBS Lett. 230, 1-5.
17. Jin, H., Xie, Z., George, S. R., and O'Dowd, B. F. (1999) Palmitoylation occurs at cysteine 347 and cysteine 351 of the dopamine D(1) receptor. Eur. J. Pharmacol. 386, 305-312.
18. Unger, V. M., Hargrave, P. A., Baldwin, J. M., and Schertler, G. F. (1997) Arrangement of rhodopsin transmembrane alpha-helices. Nature. 389, 203-206.
19. Palczewski, K., Kumasaka, T., Hori, T., et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science. 289, 739-745.
20. Dohlman, H. G., Thorner, J., Caron, M. G., and Lefkowitz, R. J. (1991) Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60, 653-688.
21. Hibert, M. F., Trumpp-Kallmeyer, S., Hoflack, J., and Bruinvels, A. (1993) This is not a G protein-coupled receptor. Trends Pharmacol. Sci. 14, 7-12.
22. Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D., and Dixon, R. A. (1994) Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63, 101-132.
23. Rana, B. K., Shiina, T., and Insel, P. A. (2001) Genetic variations and polymorphisms of G protein-coupled receptors: Functional and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41, 593-624.
24. Sadee, W., Hoeg, E., Lucas, J., and Wang, D. X. (2001) Genetic variations in human G proteincoupled receptors: implications for drug therapy. AAPS Pharmsci. 3.
25. Neves, S. R., and Iyengar, R. (2002) Modeling of signaling networks. Bioessays. 24, 1110-1117.
26. Lynch, K. R., O'Neill, G. P., Liu, Q. Y., et al. (1999) Characterization of the human cysteinyl leukotriene CysLT(1) receptor. Nature. 399, 789-793.
27. Heise, C. E., O'Dowd, B. F., Figueroa, D. J., et al. (2000) Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275, 30531-30536.
28. Figueroa, D. J., Breyer, R. M., Defoe, S. K., et al. (2001) Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Resp. Crit. Care Med. 163, 226-233.
29. Mellor, E. A., Frank, N., Soler, D., et al.. (2003) Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R. Proc. Natl. Acad. Sci. U. S. Am. 100, 11589-11593.
30. Sjostrom, M., Johansson, A. S., Schroder, O., Qiu, H., Palmblad, J., and Haeggstrom, J. Z. (2003) Dominant expression of the CysLT(2) receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells. Arterioscler. Thromb. Vase. Biol. 23, E37-E41.
31. Milligan, G. (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol. Pharmacol. 66, 1-7.
32. Gomes, I., Jordan, B. A., Gupta, A., Rios, C., Trapaidze, N., and Devi, L. A. (2001) G protein coupled receptor dimerization: implications in modulating receptor function. J. Mol. Med. 79, 226-242.
33. AbdAlla, S., Lother, H., and Quitterer, U. (2000) AT(1)-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature. 407, 94-98.
34. AbdAlla, S., Lother, H., Langer, A., el Faramawy, Y., and Quitterer, U. (2004) Factor XIIIA transglutaminase crosslinks AT(1) receptor dimers of monocytes at the onset of atherosclerosis. Cell. 119, 343-354.
35. Zeng, F. Y., and Wess, J. (1999) Identification and molecular characterization of m3 muscarinic receptor dimers. J. Biol. Chem. 274, 19487-19497.
36. 1 dopamine receptor function without affecting receptor oligomerization. J. Biol. Chem. 273, 30244-30248.
37. Lee, S. P., O'Dowd, B. F., Rajaram, R. D., Nguyen, T., and George, S. R. (2003) D2 dopamine receptor homodimerization is mediated by multiple sites of interaction, including an intermolecular interaction involving transmembrane domain 4. Biochemistry. 42, 11023-11031.
38. Romano, C., Yang, W. L., and KL, O. M. (1996) Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J. Biol. Chem. 271, 28612-28616.
39. Karnik, S. S., Sakmar, T. P., Chen, H. B., and Khorana, H. G. (1988) Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin. Proc. Natl. Acad Sci. U. S. A. 85, 8459-8463.
40. Savarese, T. M., Wang, C. D., and Fraser, C. M. (1992) Site-directed mutagenesis of the rat ml muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. J. Biol. Chem. 267, 11439-11448.
41. Zhang, P., Johnson, P. S., Zollner, C., et al. (1999) Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane. Brain Res. Mol. Brain Res. 72, 195-204.
42. Capra, V., Thompson, M. D., Cole, D. E. C., Sala, A., Folco, G., and Rovati, G. E. (2007) Cysteinyl-leukotrienes and their receptors in health and disease. Med. Res. Rev. 27, 469-527.
43. Thompson, M. D., Burnham, W. M., and Cole, D. E. C. (2005) The G protein-coupled receptors: pharmacogenetics and disease. Crii. Rev. Clin. Lab. Sci. 42, 311-392.
44. Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., and Caron, M. G. (2004) Desensitization of G protein-coupled receptors and neuronal functions. Annu. Rev. Neurosci. 27, 107-144.
45. Lefkowitz, R. J. (2004) Historical review: a brief history and personal retrospective of seven-transmembrane receptors. Trends Pharmacol. Sci. 25, 413-422.
46. Spiegel, A. M., and Weinstein, L. S. (2004) Inherited diseases involving G proteins and G protein-coupled receptors. Annu. Rev. Med. 55, 27-39.
47. Wensel, T. (1999) Introduction to cellular signal transduction. (Sitaramayya, A. ed.) Heterotrimeric G-Proteins: Structure, regulation and signaling mechanisms. Introductory Signal Transduction pp. 29-46. Birkhanser, Boston, MA.
48. Spiegel, A. M. (1996) Defects in G protein-coupled signal transduction in human disease. Annu. Rev. Physiol. 58, 143-70.
49. Sunahara, R. K., Dessauer, C. W., and Gilman, A. G. (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36, 461-480.
50. Tang, C. M., and Insel, P. A. (2005) Genetic variation in G-protein-coupled receptors-consequences for G-protein-coupled receptors as drug targets. Expert. Opin. Ther. Targets. 9, 1247-1265.
51. Rebois, R. V., and Hebert, T. E. (2003) Protein complexes involved in heptahelical receptormediated signal transduction. Receptors Channels. 9, 169-194.
52. + channel in heart. Nature. 325, 321-326.
53. Premont, R. T., Inglese, J., and Lefkowitz, R. J. (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9, 175-82.
54. Ray, K., Kunsch, C., Bonner, L. M., and Robishaw, J. D. (1995) Isolation of cDNA clones encoding eight different human G protein gamma subunits, including three novel forms designated the gamma 4, gamma 10, and gamma 11 subunits. J. Biol. Chem. 270, 21765-21771.
55. Hepler, J. R., and Gilman, A. G. (1992) G-proteins. Trends Biochem. Sei. 17, 383-387.
56. Siffert, W., Rosskopf, D., Siffert, G., et al. (1998) Association of a human G-protein beta3 subunit variant with hypertension. Nat. Genet. 18, 45-48.
57. Sun, A., Ge, J., Siffert, W., and Frey, U. H. (2005) Quantification of allele-specific G-protein beta3 subunit mRNA transcripts in different human cells and tissues by Pyrosequencing. Eur. J. Hum. Genet. 13, 361-369.
58. Siffert, W. (2001) Molecular genetics of G proteins and atherosclerosis risk. Basic Res. Cardiol. 96, 606-611.
59. Mitchell, A., Pace, M., Nürnberger, J., et al. (2005) Insulin-mediated venodilation is impaired in young, healthy carriers of the 825T allele of the G-protein beta3 subunit gene (GNB3). Clin. Pharmacol. Ther. 77, 495-502.
60. Matsunaga, T., Nagasumi, K., Yamamura, T., et al. (2005) Association of C825T polymorphism of G protein beta3 subunit with the autonomic nervous system in young healthy Japanese individuals. Am. J. Hypertens. 18, 523-529.
61. Kiani, J. G., Saeed, M., Parvez, S. H., and Frossard, P. M. (2005) Association of G-protein beta-3 subunit gene (GNB3) T825 allele with type II diabetes. Neuro. Endocrinol. Lett. 26, 87-88.
62. Fernandez-Real, J. M., Penarroja, G., Richart, C., et al. (2003) G protein beta3 gene variant, vascular function, and insulin sensitivity in type 2 diabetes. Hypertension. 41, 124-129.
63. Terra, S. G., McGorray, S. P., Wu, R., et al. (2005) Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study. Int. J Obes. (Lond). 29, 746-754.
64. Andersen, G., Overgaard, J., Albrechtsen, A., et al. (2006) Studies of the association of the GNB3 825C>T polymorphism with components of the metabolic syndrome in white Danes. Diabetologia. 49, 75-82.
65. Meirhaeghe, A., Cottel, D., Amouyel, P., and Dallongeville, J. (2005) Lack of association between certain candidate gene polymorphisms and the metabolic syndrome. Mol. Genet. Metab. 86, 293-299.
66. Bullido, M. J., Ramos, M. C., Ruiz-Gomez, A., et al. (2004) Polymorphism in genes involved in adrenergic signaling associated with Alzheimer's. Neurobiol. Aging. 25, 853-859.
67. Klintschar, M., Stiller, D., Schwaiger, P., and Kleiber, M. (2005) DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: association with unexpected death from acute myocardial infarction and increased heart weight. Forensic Sci. Int. 153, 142-146.
68. Eisenhardt, A., Siffert, W., Rosskopf, D., et al. (2005) Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer. World J. Urol. 23, 279-286.
69. Sheu, S. Y., Gorges, R., Ensinger, C., et al. (2005) Different genotype distribution of the GNB3 C825T polymorphism of the G protein beta3 subunit in adenomas and differentiated thyroid carcinomas of follicular cell origin. J. Pathol. 207, 430-435.
70. Sarrazin, C., Berg, T., Weich, V., et al. (2005) GNB3 C825T polymorphism and response to interferon-alfa/ribavirin treatment in patients with hepatitis C virus genotype 1 (HCV-1) infection. J. Hepatol. 43, 388-393.
71. Lee, H. J., Cha, J. H., Ham, B. J., et al. (2004) Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics. J. 4, 29-33.
72. Muller, D. J., De, L., V, Sicard, T., et al. (2005) Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia. Eur. Neuropsychopharmacol. 15, 525-531.
73. Schelleman, H., Strieker, B. H., Verschuren, W. M., et al. (2006) Interactions between five candidate genes and antihypertensive drug therapy on blood pressure. Pharmacogenomics. J. 6, 22-26.
74. Muller, S., and Lohse, M. J. (1995) The role of G-protein beta gamma subunits in signal transduction. Biochem. Soc. Trans. 23, 141-148.
75. Tang, W. J., and Gilman, A. G. (1991) Type-specific regulation of adenylyl cyclase by G protein beta gamma subunits. Science. 254, 1500-1503.
76. Ueda, N., Iniguez-Lluhi, J. A., Lee, E., Smrčka, A. V., Robishaw, J. D., and Gilman, A. G. (1994) G protein beta gamma subunits. Simplified purification and properties of novel isoforms. J. Biol. Chem. 269, 4388-4395.
77. Boyer, J. L., Graber, S. G., Waldo, G. L., Harden, T. K., and Garrison, J. C. (1994) Selective activation of phospholipase C by recombinant G-protein alpha- and beta gamma-subunits. J. Biol. Chem. 269, 2814-2819.
78. Carty, D. J., Padrell, E., Codina, J., Birnbaumer, L., Hildebrandt, J. D., and Iyengar, R. (1990) Distinct guanine nucleotide binding and release properties of the three Gi proteins. J. Biol. Chem. 265, 6268-6273.
79. Bourne, H. R., and Stryer, L. (1992) G proteins. The target sets the tempo [news]. Nature. 358, 541-543.
80. Tanabe, S., Kreutz, B., Suzuki, N., and Kozasa, T. (2004) Regulation of RGS-RhoGEFs by G alpha 12 and G alpha 13 proteins. Reg. G-Protein Signal. B. 390, 285-294.
81. Weinstein, L. S., Chen, M., Xie, T., and Liu, J. (2006) Genetic diseases associated with heterotrimeric G proteins. Trends Pharmacol. Sci. 27, 260-266.
82. Gejman, P. V., Weinstein, L. S., Martinez, M., et al. (1991) Genetic mapping of the Gs-alpha subunit gene (GNAS1) to the distal long arm of chromosome 20 using a polymorphism detected by denaturing gradient gel electrophoresis. Genomics. 9, 782-783.
83. Shenker, A., Weinstein, L. S., Sweet, D. E., and Spiegel, A. M. (1994) An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J. Clin. Endocrinol. Metab. 79, 750-755.
84. Fragoso, M. C., Domenice, S., Latronico, A. C., et al. (2003) Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J. Clin. Endocrinol. Metab. 88, 2147-2151.
85. Roman, R., Johnson, M. C., Codner, E., Boric, M. A., Avila, A., and Cassorla, F. (2004) Activating GNAS1 gene mutations in patients with premature thelarche. J. Pediatr. 145, 218-222.
86. Spiegel, A. M. (1990) Albright's hereditary osteodystrophy and defective G proteins. N. Engl. J Med. 322, 1461-1462.
87. Weinstein, L. S., Yu, S., Warner, D. R., and Liu, J. (2001) Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting. Endocr. Rev. 22, 675-705.
88. Bastepe, M., Weinstein, L. S., Ogata, N., et al. (2004) Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc. Natl. Acad. Sci. U. S. A. 101, 14794-14799.
89. Sakamoto, A., Chen, M., Kobayashi, T., Kronenberg, H. M., and Weinstein, L. S. (2005) Chondrocyte-specific knockout of the G protein G(s)alpha leads to epiphyseal and growth plate abnormalities and ectopic chondrocyte formation. J. Bone Miner. Res. 20, 663-671.
90. Germain-Lee, E. L., Groman, J., Crane, J. L., Jan de Beur, S. M., and Levine, M. A. (2003) Growth hormone deficiency in pseudohypoparathyroidism type la: another manifestation of multihormone resistance. J. Clin. Endocrinol. Metab. 88, 4059-4069.
91. Mantovani, G., Maghnie, M., Weber, G., et al. (2003) Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs alpha gene. J. Clin. Endocrinol. Metab. 88, 4070-4074.
92. Yu, S., Yu, D., Lee, E., Eckhaus, M., et al. (1998) Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc. Natl. Acad. Sci. U. S. A. 95, 8715-8720.
93. Hayward, B. E., Barlier, A., Korbonits, M., et al. (2001) Imprinting of the G(s)alpha gene GNASl in the pathogenesis of acromegaly. J. Clin. Invest. 107, R31-R36.
94. Mantovani, G., Bailare, E., Giammona, E., Beck-Peccoz, P., and Spada, A. (2002) The gsalpha gene: predominant maternal origin of transcription in human thyroid gland and gonads. J. Clin. Endocrinol. Metab. 87, 4736-4740.
95. Germain-Lee, E. L., Ding, C. L., Deng, Z., et al. (2002) Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type la. Biochem. Biophys. Res. Commun. 296, 67-72.
96. Liu, J., Erlichman, B., and Weinstein, L. S. (2003) The stimulatory G protein alpha-subunit Gs alpha is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism types 1A and IB. J. Clin. Endocrinol. Metab. 88, 4336-4341.
97. Bastepe, M., Frohlich, L. F., Linglart, A., et al. (2005) Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat. Genet 37, 25-27.
98. Bastepe, M., Lane, A. H., and Juppner, H. (2001) Paternal uniparental isodisomy of chromosome 20q - and the resulting changes in GNAS1 methylation - as a plausible cause of pseudohypoparathyroidism. Am. J. Hum. Genet 68, 1283-1289.
99. Wu, W. I., Schwindinger, W. F., Aparicio, L. F., and Levine, M. A. (2001) Selective resistance to parathyroid hormone caused by a novel uncoupling mutation in the carboxyl terminus of G alpha(s). A cause of pseudohypoparathyroidism type Ib. J. Biol. Chem. 276, 165-171.
100. Cismowski, M. J. (2006) Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins). Semin. Cell Dev. Biol. 17, 334-344.
101. Sato, M., Cismowski, M. J., Toyota, E., et al. (2006) Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc. Natl. Acad. Sci. U. S. A. 103, 797-802.
102. Hall, R. A., and Lefkowitz, R. J. (2002) Regulation of G protein-coupled receptor signaling by scaffold proteins. Circ. Res. 91, 672-680.
103. De Vries, L., Zheng, B., Fischer, T., Elenko, E., and Farquhar, M. G. (2000) The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40, 235-271.
104. Hepler, J. R. (2003) RGS protein and G protein interactions: A little help from their friends. Mol. Pharmacol. 64, 547-549.
105. Roy, A. A., Lemberg, K E., and Chidiac, P. (2003) Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. Mol. Pharmacol. 64, 587-593.
106. Cismowski, M. J. (2006) Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins). Semin. Cell Dev. Biol. 17, 334-344.
107. Sato, M., Cismowski, M. J., Toyota, E., et al. (2006) Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc. Natl. Acad. Sci. U. S. A. 103, 797-802.
108. Cismowski, M. J. (2006) Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins). Semin. Cell Dev. Biol. 17, 334-344.
109. Sato, M., Cismowski, M. J., Toyota, E., et al. (2006) Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc. Natl. Acad. Sci. U. S. A. 103, 797-802.
110. Riddle, E. L., Rana, B. K., Murthy, K K., Rao, F., Eskin, E., O'Connor, D. T., and Insel, P. A. (2006) Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension. 47, 415-420.
111. Chidiac, P., and Roy, A. A. (2003) Activity, regulation, and intracellular localization of RGS proteins. Receptors Channels. 9, 135-147.
112. Bernstein, L. S., Ramineni, S., Hague, C., et al. (2004) RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate G(q/11 alpha) signaling. J. Biol. Chem. 279, 21248-21256.
113. Heximer, S. P., Knutsen, R. H., Sun, X., et al. (2003) Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111, 1259.
114. Sun, X., Kaltenbronn, K. M., Steinberg, T. H., and Blumer, K. J. (2005) RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol. Pharmacol. 67, 631-639.
115. Tiret, L., Bonnardeaux, A., Poirier, O., et al. (1994) Synergistic effects of angiotensin-converting enzyme and angiotensin-II type-1 receptor gene polymorphisms on risk of myocardial-infarction. Lancet. 344, 910-913.
116. Takami, S., Katsuya, T., Rakugi, H., et al. (1998) Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am. J. Hypertens. 11, 316-321.
117. Calo, L. A., Pagnin, E., Davis, P. A., et al. (2004) Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension. J. Clin. Endocrinol. Metab. 89, 4153-4157.
118. Gao, Y., Portugal, A. D., Negash, S., Zhou, W., Longo, L. D., and Raj, J. U. (2007) Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia. Am. J. Physiol Lung Cell. Mol. Physiol. 292, L678-L684.
119. Riddle, E. L., Schwartzman, R. A., Bond, M., and Insel, P. A. (2005) Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ. Res. 96, 401-411.
120. Semplicini, A., Lenzini, L., Sartori, M., et al. (2006) Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J. Hypertens. 24, 1115-1124.
121. Salomon, Y., Londos, C., and Rodbell, M. (1974) A highly sensitive adenylate cyclase assay. Anal. Biochem. 58, 541-548.
122. Lamey, M., Thompson, M., Varghese, G., et al. (2002) Distinct residues in the carboxyl tail mediate agonist-induced desensitization and internalization of the human dopamine D-1 receptor. J. Biol. Chem. 211, 9415-9421.
123. Krupnick, J. G., and Benovic, J. L. (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38, 289-319.
124. Zhao, X., Palczewski, K., and Ohguro, H. (1995) Mechanism of rhodopsin phosphorylation. Biophys. Chem. 56, 183-188.
125. Jiang, D., and Sibley, D. R. (1999) Regulation of D(1) dopamine receptors with mutations of protein kinase phosphorylation sites: attenuation of the rate of agonist-induced desensitization. Mol. Pharmacol. 56, 675-683.
126. Hausdorff, W. P., Bouvier, M., O'Dowd, B. F., Irons, G. P., Caron, M. G., and Lefkowitz, R. J. (1989) Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. J. Biol. Chem. 264, 12657-12665.
127. Lohse, M. J., Benovic, J. L., Caron, M. G., and Lefkowitz, R. J. (1990) Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J. Biol. Chem. 265, 3202-3211.
128. Lohse, M. J. (1993) Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta. 1179, 171-188.
129. 1A dopamine receptor: efficacy in causing desensitization dissociates from both receptor occupancy and functional potency. J. Pharmacol. Exp. Ther. 286, 345-353.
130. Shih, M., and Malbon, C. C. (1994) Oligodeoxynucleotides antisense to mRNA encoding protein kinase A, protein kinase C, and beta-adrenergic receptor kinase reveal distinctive cell-type-specific roles in agonist-induced desensitization. Proc. Natl. Acad. Sci. U. S. A. 91, 12193-12197.
131. Roth, N. S., Campbell, P. T., Caron, M. G., Lefkowitz, R. J., and Lohse, M. J. (1991) Comparative rates of desensitization of beta-adrenergic receptors by the beta-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 88, 6201-6204.
132. Eason, M. G., Moreira, S. P., and Liggett, S. B. (1995) Four consecutive serines in the third intracellular loop are the sites for beta-adrenergic receptor kinase-mediated phosphorylation and desensitization of the alpha 2A-adrenergic receptor. J. Biol. Chem. 270, 4681-4688.
133. Diviani, D., Lattion, A. L., and Cotecchia, S. (1997) Characterization of the phosphorylation sites involved in G protein- coupled receptor kinase- and protein kinase C-mediated desensitization of the alpha1B-adrenergic receptor. J. Biol. Chem. 272, 28712-28719.
134. Maestes, D. C., Potter, R. M., and Prossnitz, E. R. (1999) Differential phosphorylation paradigms dictate desensitization and internalization of the N-formyl peptide receptor. J. Biol. Chem. 274, 29791-29795.
135. Tsuga, H., Kameyama, K., Haga, T., Honma, T., Lameh, J., and Sadee, W. (1998) Internalization and down-regulation of human muscarinic acetylcholine receptor m2 subtypes. Role of third intracellular m2 loop and G protein- coupled receptor kinase 2. J. Biol. Chem. 213, 5323-5330.
136. Pals-Rylaarsdam, R., and Hosey, M. M. (1997) Two homologous phosphorylation domains differentially contribute to desensitization and internalization of the m2 muscarinic acetylcholine receptor. J. Biol. Chem. 272, 14152-14158.
137. 1A receptor responsiveness by various G protein-coupled receptor kinases. J. Biol. Chem. 271, 3771-3778.
138. Bouvier, M., Hausdorff, W. P., de Blasi, A., et al. (1988) Removal of phosphorylation sites from the beta 2-adrenergic receptor delays onset of agonist-promoted desensitization. Nature. 333, 370-373.
139. Hausdorff, W. P., Campbell, P. T., Ostrowski, J., Yu, S. S., Caron, M. G., and Lefkowitz, R. J. (1991) A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation. Proc. Natl. Acad. Sci. U. S. A. 88, 2979-2983.
140. Fredericks, Z. L., Pitcher, J. A., and Lefkowitz, R. J. (1996) Identification of the G proteincoupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor. J. Biol. Chem. 271, 13796-13803.
141. Seibold, A., January, B. G., Friedman, J., Hipkin, R. W., and Clark, R. B. (1998) Desensitization of beta2-adrenergic receptors with mutations of the proposed G protein-coupled receptor kinase phosphorylation sites. J. Biol. Chem. 273, 7637-7642.
142. Pak, Y., O'Dowd, B. F., and George, S. R. (1997) Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J. Biol. Chem. 272, 24961-24965.
143. Guo, J., Wu, Y., Zhang, W., Zhao, J., Devi, L. A., Pei, G., and Ma, L. (2000) Identification of G protein-coupled receptor kinase 2 phosphorylation sites responsible for agonist-stimulated delta-opioid receptor phosphorylation. Mol. Pharmacol. 58, 1050-1056.
144. Palmer, T. M., Benovic, J. L., and Stiles, G. L. (1995) Agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Evidence for a G-protein-coupled receptor kinase- mediated mechanism. J. Biol. Chem. 270, 29607-29613.
145. Palmer, T. M., Stiles, G. L. (1997) Identification of an A2a adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry. 36, 832-838.
146. Palmer, T. M., Stiles, G. L. (2000) Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A(3) adenosine receptor [in process citation]. Mol Pharmacol 57, 539-545.
147. 1 dopamine receptor. J. Biol. Chem. 279, 37461-37469.
148. Ohguro, H., Van Hooser, J. P., Milam, A. H., and Palczewski, K. (1995) Rhodopsin phosphorylation and dephosphorylation in vivo. J. Biol. Chem. 270, 14259-14262.
149. Thompson, M. D., Burnham, W. M., and Cole, D. E. (2005) The G protein-coupled receptors: pharmacogenetics and disease. Crit Rev. Clin Lab Sci. 42, 311-392.
150. 1 dopamine receptor desensitization: evidence for a novel mechanism of arrestin association. J Biol. Chem. 279, 7999-8010.
151. Ferguson, S. S., Barak, L. S., Zhang, J., and Caron, M. G. (1996) G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can. J. Physiol. Pharmacol. 74, 1095-1110.
152. Ferguson, S. S., Downey, W. E. 3., Colapietro, A. M., Barak, L. S., Menard, L., and Caron, M. G. (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science. 271, 363-366.
153. Faussner, A., Proud, D., Towns, M., and Bathon, J. M. (1998) Influence of the cytosolic carboxyl termini of human B1 and B2 kinin receptors on receptor sequestration, ligand internalization, and signal transduction. J. Biol. Chem. 273, 2617-2623.
154. Tan, C. M., Brady, A. E., Nickols, H. H., Wang, Q., and Limbird, L. E. (2004) Membrane trafficking of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44, 559-609.
155. Pals-Rylaarsdam, R., Xu, Y., Witt-Enderby, P., Benovic, J. L., and Hosey, M. M. (1995) Desensitization and internalization of the m2 muscarinic acetylcholine receptor are directed by independent mechanisms. J. Biol. Chem. 270, 29004-29011.
156. Seibold, A., Williams, B., Huang, Z. F., et al. (2000) Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. Mol. Pharmacol. 58, 1162-1173.
157. Pak, Y., O'Dowd, B. F., Wang, J. B., and George, S. R. (1999) Agonist-induced, G proteindependent and -independent down-regulation of the mu opioid receptor. The receptor is a direct substrate for protein-tyrosine kinase. J. Biol. Chem. 274, 27610-27616.
158. Hasbi, A., Allouche, S., Sichel, F., et al. (2000) Internalization and recycling of delta-opioid receptor are dependent on a phosphorylation- dephosphorylation mechanism. J. Biol. Chem. 293, 237-247.
159. Mathuru, A. L., Mundell, S. L., Benovic, J. L., and Kelly, E. (2001) Rapid agonist-induced desensitization and internalization of the a2b adenosine receptor is mediated by a serine residue close to the COOH terminus. J. Biochem. 276, 30199-30207.
160. Holtmann, M. H., Roettger, B. F., Pinon, D. I., and Miller, L. J. (1996) Role of receptor phosphorylation in desensitization and internalization of the secretin receptor. J. Biol. Chem. 271, 23566-23571.
161. Moffett, S., Rousseau, G., Lagace, M., and Bouvier, M. (2001) The palmitoylation state of the beta2-adrenergic receptor regulates the synergistic action of cyclic AMP-dependent protein kinase and beta2-adrenergic receptor kinase involved in its phosphorylation and desensitization. J. Neurochem. 76, 269-279.
162. Lee, K. B., Ptasienski, J. A., Pals-Rylaarsdam, R., Gurevich, V. V., and Hosey, M. M. (2000) Arrestin binding to the M(2) muscarinic acetylcholine receptor is precluded by an inhibitory element in the third intracellular loop of the receptor. J. Biol. Chem. 275, 9284-9289.
163. Goodman, O. B., Jr., Krupnick, J. G., Santini, F., et al. (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2- adrenergic receptor. Nature. 383, 447-450.
164. Hinshaw, J. E., and Schmid, S. L. (1995) Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding [see comments]. Nature. 374, 190-192.
165. Takei, K., McPherson, P. S., Schmid, S. L., and De Camilli, P. (1995) Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals [see comments]. Nature. 374, 186-190.
166. Schmid, S. L. (1992) The mechanism of receptor-mediated endocytosis - more questions than answers. Bioessays. 14, 589-596.
167. Lefkowitz, R. J. (1998) G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273, 18677-18680.
168. Freedman, N. J., and Lefkowitz, R. J. (1996) Desensitization of G protein-coupled receptors. Recent Prog. Horm. Res. 51, 319-351.
169. Pitcher, J. A., Freedman, N. J., and Lefkowitz, R. J. (1998) G protein-coupled receptor kinases. Annu. Rev. Biochem. 67, 653-692.
170. Krueger, K M., Daaka, Y., Pitcher, J. A., and Lefkowitz, R. J. (1997) The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification. J. Biol. Chem. 272, 5-8.
171. Pippig, S., Andexinger, S., and Lohse, M. J. (1995) Sequestration and recycling of beta 2-adrenergic receptors permit receptor resensitization. Mol. Pharmacol. 47, 666-676.
172. Koenig, J. A., and Edwardson, J. M. (1997) Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol. Sci. 18, 276-287.
173. Barak, L. S., Tiberi, M., Freedman, N. J., Kwatra, M. M., Lefkowitz, R. J., and Caron, M. G. (1994) A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration. J. Biol. Chem. 269, 2790-2795.
174. Gabilondo, A. M., Hegler, J., Krasel, C., Boivin-Jahns, V., Hein, L., and Lohse, M. J. (1997) A dileucine motif in the C terminus of the beta2-adrenergic receptor is involved in receptor internalization. Proc. Natl. Acad. Sci. U. S. A. 94, 12285-12290.
175. Preisser, L., Ancellin, N., Michaelis, L., Creminon, C., Morel, A., and Corman, B. (1999) Role of the carboxyl-terminal region, di-leucine motif and cysteine residues in signalling and internalization of vasopressin Via receptor. FEBS Lett. 460, 303-308.
176. Benya, R. V., Fathi, Z., Battey, J. F., and Jensen, R. T. (1993) Serines and threonines in the gastrin-releasing peptide receptor carboxyl terminus mediate internalization. J. Biol. Chem. 268, 20285-20290.
177. Roth, A., Kreienkamp, H. J., Meyerhof, W., and Richter, D. (1997) Phosphorylation of four amino acid residues in the carboxyl terminus of the rat somatostatin receptor subtype 3 is crucial for its desensitization and internalization. J. Biol. Chem. 272, 23769-23774.
178. Pizard, A., Blaukat, A., Muller-Esterl, W., Alhenc-Gelas, F., and Rajerison, R. M. (1999) Bradykinin-induced internalization of the human B2 receptor requires phosphorylation of three serine and two threonine residues at its carboxyl tail [in process citation]. J. Biol. Chem. 274, 12738-12747.
179. Kennelly, P. J., and Krebs, E. G. (1991) Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266, 15555-15558.
180. Onorato, J. J., Palczewski, K., Regan, J. W., Caron, M. G., Lefkowitz, R. J., and Benovic, J. L. (1991) Role of acidic amino acids in peptide substrates of the beta-adrenergic receptor kinase and rhodopsin kinase. Biochemistry. 30, 5118-5125.
181. Inglese, J., Freedman, N. J., Koch, W. J., and Lefkowitz, R. J. (1993) Structure and mechanism of the G protein-coupled receptor kinases. J. Biol. Chem. 268, 23735-23738.
182. Oppermann, M., Diverse-Pierluissi, M., Drazner, M. H., et al. (1996) Monoclonal antibodies reveal receptor specificity among G-protein-coupled receptor kinases. Proc. Natl. Acad. Sci. U. S. A. 93, 7649-7654.
183. Chen, C. K., Zhang, K., Church-Kopish, J., et al. (2001) Characterization of human GRK7 as a potential cone opsin kinase. Mol. Vision. 1, 305-313.
184. Min, L., and Ascoli, M. (2000) Effect of activating and inactivating mutations on the phosphorylation and trafficking of the human lutropin/choriogonadotropin receptor. Mol. Endocrinol. 14, 1797-1810.
185. Loudon, R. P., and Benovic, J. L. (1994) Expression, purification, and characterization of the G protein-coupled receptor kinase GRK6. J. Biol. Chem. 269, 22691-22697.
186. Rankin, M. L., Marinee, P. S., Cabrera, D. M., Wang, Z., Jose, P. A., and Sibley, D. R. (2006) The D1 dopamine receptor is constitutively phosphorylated by G protein-coupled receptor kinase 4. Mol. Pharmacol. 69, 759-769.
187. 1 dopamine receptor hyperphosphorylation in renal proximal tubules in hypertension. Kidney Int. 70, 1072-1079.
188. Felder, R. A., and Jose, P. A. (2006) Mechanisms of disease: the role of GRK4 in the etiology of essential hypertension and salt sensitivity. Nat. Clin. Pract. Nephrol. 2, 637-650.
189. Dryja, T. P. (2000) Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am. J. Ophthalmol. 130, 547-563.
190. Sandberg, M. A., WeigelDiFranco, C., Rosner, B., and Berson, E. L. (1996) The relationship between visual field size and electroretinogram amplitude in retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 37, 1693-1698.
191. Cideciyan, A. V., Zhao, X., Nielsen, L., Khani, S. C., Jacobson, S. G., and Palczewski, K (1998) Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc. Natl. Acad. Sci. U. S. A. 95, 328-333.
192. Shenker, A. (1995) G protein-coupled receptor structure and function: the impact of disease-causing mutations. Baillieres Clin. Endocrinol. Metab. 9, 427-451.